1.
Transplant Proc
; 46(1): 281-3, 2014.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24507068
RESUMEN
Pregnancy after kidney transplantation is becoming more common as more patients of childbearing age are undergoing successful transplantation. There is limited evidence on the safety and efficacy of mammalian target of rapamycin inhibitors during pregnancy, which are considered Category C. We will review the use of this class of medications in pregnancy, which is currently contraindicated due to risk of fetal complications. We will also present the case of a successful pregnancy and renal outcome in a 33-year-old kidney transplant recipient who was administered everolimus throughout pregnancy.
Asunto(s)
Inmunosupresores/administración & dosificación , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/cirugía , Trasplante de Riñón , Exposición Materna , Sirolimus/análogos & derivados , Adulto , Everolimus , Femenino , Humanos , Inmunosupresores/efectos adversos , Recién Nacido , Masculino , Seguridad del Paciente , Embarazo , Complicaciones del Embarazo , Resultado del Embarazo , Riesgo , Sirolimus/administración & dosificación , Sirolimus/efectos adversos , Resultado del Tratamiento
2.
Ann Dent
; 39(2): 28-30, 1980.
Artículo
en Inglés
| MEDLINE
| ID: mdl-6930195
3.
Change
; 9(10): 19, 60-1, 1977 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-10323901